PeptideStack
5.2kquestions
20kanswers
220users

Does a slower rate of loss reduce gallstone risk in practice?

Asked 29 Nov 2024Modified 16 months agoViewed 52k times
31

For the avoidance of doubt, nothing here is urgent — I would be in a clinic rather than a text box.

This is one of those things that everyone repeats and nobody derives.

This matters practically, not just academically, because it changes what I would do next.

Is the standard explanation correct, and if so, what is the evidence for it?

gallbladder
gallbladder

Cholelithiasis and cholecystitis risk during rapid weight loss and on treatment: how much is attributable to the rate of loss versus to the drug,…

8 questions
gi-side-effects
gi-side-effects

The gastrointestinal cluster as a whole - nausea, vomiting, diarrhoea, constipation, reflux, early satiety - with trial incidence rates, dropout…

162 questions
clinical-trials
clinical-trials

Reading the primary literature properly: estimands, intention-to-treat versus per-protocol, confidence intervals, absolute versus relative…

745 questions
shareeditfollowflag
ID
askedines_delacruz16k1629 Nov 2024

5 Answers

Accepted answer first, then by votes
86

Accepted answer

Start with the rate of loss, because that is the variable the risk actually tracks.

Loss rates above about 1.5 kilograms a week are where the risk climbs most steeply in the older literature, which is a practical argument against the fastest possible trajectory.

Gastrointestinal adverse events, indicative pooled rates

EventActive armPlacebo armTiming
Nausea40–45 %15–20 %Peaks 1–2 wk after each step
Vomiting15–25 %5–8 %Follows nausea
Diarrhoea20–30 %10–15 %Early, variable
Constipation20–25 %8–12 %Later onset, persistent
Discontinuation for GI events4–7 %1–2 %Mostly during escalation

Ranges span agents and doses; read the specific prescribing information for a specific figure.

Including some dietary fat at meals maintains gallbladder contraction. A near-zero-fat diet during rapid loss is the combination that maximises risk, which inverts the intuitive advice.

The dual mechanism — raised biliary cholesterol saturation plus reduced gallbladder emptying — is established from bile composition and motility studies.

Keep some fat in meals. A zero-fat diet stops the gallbladder emptying.

shareimprove this answerflag
DS
answered · acceptedDr_Hanne_Solberg36k275 Dec 2024
Sponsored

Janoshik Analytical - Independent Third-Party Testing

HPLC purity, identity confirmation and quantified content on the vial you actually hold. Reports arrive with the chromatogram attached, not just a number.

Submit a sample
Sponsored — paired listing

GL Biochem (Shanghai) Ltd. - Direct Synthesis

Founded 1998. ISO 9001 and cGMP certified, 1,500+ staff and 200+ patents. The synthesis house behind a great many of the vials that get sent out for testing - batch-specific documentation with every order.

Visit GL Biochem
32

This is one of the few adverse outcomes in this class with a clean mechanistic explanation and a clear modifiable factor.

Fever, jaundice or persistent pain beyond a few hours suggests complication rather than simple colic and is urgent.

In practice, biliary colic presents as severe right-upper-quadrant or epigastric pain, often after a fatty meal, lasting from thirty minutes to several hours, sometimes radiating to the right shoulder blade.

Prophylaxis is a prescribing decision that depends on individual risk, not a general recommendation.

Rate of loss is the modifiable factor. Slower is genuinely safer here.

shareimprove this answerflag
DA
answeredDr_Rosalind_Achebe69k14717 Dec 2024
2Thank you — this is the answer I was looking for. – v_ramaswamy 9 months ago
add a comment
24

Answering this needs to know the rate and whether there is a history of stones, since prior stones change the picture materially.

The trial programmes in this class report cholelithiasis at low single-figure percentages, higher than placebo, consistent with the weight-loss mechanism rather than a novel one.

Concretely, ursodeoxycholic acid has evidence for reducing stone formation during rapid weight loss and is a prescribing decision rather than a supplement choice.

Research-use compounds are not approved for human use.

Fever or jaundice with pain is urgent. Do not wait.

shareimprove this answerflag
GS
answeredgradient_slope46k3813 Mar 2025
2This is the first explanation of the timing pattern that has actually made sense to me. – RP_C18 7 days ago
Adding a vote because this deserves more of them. – tare_weight 8 months ago
add a comment
19

It helps to be literal here: biliary colic presents characteristically and is worth being able to recognise.

The historical figure from very-low-energy diet studies is that gallstones form in a substantial minority — often quoted between ten and twenty-five per cent — during rapid loss, with a much smaller fraction becoming symptomatic.

Trial programmes in this class report cholelithiasis as an adverse event at rates above placebo and consistent with the magnitude of weight loss achieved.

This is a weight-loss risk with a known mechanism, not a mysterious drug effect.

edited 23 Feb 2025 by Dr_Wren_Halliday — added a caveat about sampling

shareimprove this answerflag
DH
answeredDr_Wren_Halliday19k3719 Feb 2025
8Worth flagging that this presents differently in people who titrated faster than the label. – charge_state_3 7 months ago
Thank you — knowing this was expected rather than alarming was most of what I needed. – Dr_Priya_Raghunathan 9 months ago
add a comment
18

Answer first: gallstone formation is associated with rapid weight loss by a well-understood mechanism, and it is a weight-loss risk rather than a drug-specific one.

Two mechanisms operate together during rapid loss: cholesterol mobilised from adipose tissue is excreted into bile, raising its cholesterol saturation index; and reduced fat intake reduces cholecystokinin release, so the gallbladder contracts less often.

Nothing here is medical advice.

Recognise biliary colic: right upper quadrant, after fatty food, thirty minutes to hours.

shareimprove this answerflag
FF
answeredfibre_or_fragment13k3824 Mar 2025

Your answer

Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.

Not medical advice. Research-use-only compounds are not approved for human use.